Abstract: Methods of antenna pointing and antenna assemblies implementing those methods are disclosed. An example method includes providing a user terminal antenna assembly including an antenna and an auto-peak device. The antenna includes a reflector, a subreflector, and a feed, the feed oriented relative to the reflector and the subreflector to produce a beam. The antenna further includes a tilt assembly to tilt the subreflector relative to the reflector and the feed. The method further includes providing a control signal to tilt the subreflector in a plurality of tilt positions to move the beam while measuring corresponding signal strength of a signal communicated via the antenna at each of the plurality of tilt positions. Additionally, the method includes selecting a tilt position from the plurality of tilt positions based on a measured signal strength, and providing the control signal to tilt the subreflector to the selected tilt position.

Abstract: Provided herein are methods, computer programs, and systems for automated microinjection, for example, automated Intracytoplasmic Sperm Injection (ICSI).

Abstract: A sensor system including an optical fiber comprising a first spatial channel and a second spatial channel, wherein the spatial channels are coupled and electromagnetic radiation propagates with different group velocities in each of the spatial channels. The sensor system further includes a source inputting the electromagnetic radiation into the first spatial channel at an input; and a detection system coupled to an output of the fiber, the detection system including a detector detecting transmission of the electromagnetic radiation coupled into the second spatial channel at different positions along the fiber between the input to the output, and generating a signal in response thereto; and a computer processing the signal to obtain a localized measurement of a physical parameter at one or more of the different positions along the fiber.

Abstract: Methods of antenna pointing and antenna assemblies implementing those methods are disclosed. An example method includes providing a user terminal antenna assembly including an antenna and an auto-peak device. The antenna includes a reflector, a subreflector, and a feed, the feed oriented relative to the reflector and the subreflector to produce a beam. The antenna further includes a tilt assembly to tilt the subreflector relative to the reflector and the feed. The method further includes providing a control signal to tilt the subreflector in a plurality of tilt positions to move the beam while measuring corresponding signal strength of a signal communicated via the antenna at each of the plurality of tilt positions. Additionally, the method includes selecting a tilt position from the plurality of tilt positions based on a measured signal strength, and providing the control signal to tilt the subreflector to the selected tilt position.

Abstract: Methods of antenna pointing and antenna assemblies implementing those methods are disclosed. An example method includes providing a user terminal antenna assembly including an antenna and an auto-peak device. The antenna includes a reflector, a subreflector, and a feed, the feed oriented relative to the reflector and the subreflector to produce a beam. The antenna further includes a tilt assembly to tilt the subreflector relative to the reflector and the feed. The method further includes providing a control signal to tilt the subreflector in a plurality of tilt positions to move the beam while measuring corresponding signal strength of a signal communicated via the antenna at each of the plurality of tilt positions. Additionally, the method includes selecting a tilt position from the plurality of tilt positions based on a measured signal strength, and providing the control signal to tilt the subreflector to the selected tilt position.

Abstract: The present invention provides a method of preventing or treating a Mycobacterium tuberculosis (Mtb) infection in a mammal the method comprising administering to the mammal a first inhibitor, wherein the first inhibitor is an inhibitor of heme degradation and wherein the first inhibitor is a metal protoporphyrin, and administering to the mammal a second inhibitor, wherein the second inhibitor is an inhibitor of Mtb, wherein administration of the first and second inhibitors to the mammal prevents or treats Mtb infection in the mammal.

Abstract: The invention relates to a method for the dispersion of synthetic or natural nanoparticles and nanocomposite materials and to the use thereof in different sectors including those of ceramics, coatings, polymers, construction, paints, catalysis, pharmaceuticals and powdered materials in general.

Abstract: The invention relates to a method for the dispersion of synthetic or natural nanoparticles and nanocomposite materials and to the use thereof in different sectors including those of ceramics, coatings, polymers, construction, paints, catalysis, pharmaceuticals and powdered materials in general.

Abstract: A method and system to consistently and automatically conditioning and delivering a solid-free liquid (filtrate) sample suitable for instrumental analysis is disclosed. A slurry, preferably a slurry produced by a sub-atmospheric pressure chlorate dioxide generating process, is fed through a filter to remove the solid phase and to provide the liquid phase on the downstream side of the filter, where the concentration of at least one dissolved component is determined.

Abstract: A method and system to consistently and automatically conditioning and delivering a solid-free liquid (filtrate) sample suitable for instrumental analysis is disclosed. A slurry, preferably a slurry produced by a sub-atmospheric pressure chlorate dioxide generating process, is fed through a filter to remove the solid phase and to provide the liquid phase on the downstream side of the filter, where the concentration of at least one dissolved component is determined.

Abstract: The invention relates to the use of phospholipases, v.gr. sPLA2, as an active agent in the production of pharmaceutical and/or cosmetic compositions for the treatment of diseases caused by micro-organisms, the envelope or membrane of which comprises phospholipids, particularly glycerophospholipids. In particular, said invention relates to the use of sPLA2 from Crotalus durissus terrificus venom as a biocide component for the preparation of compositions for the treatment of viral infections, particularly acquired immunodeficiency states VIH-1 and VIH-2, bacterial and parasitic infections, such as infections caused by plasmodium and leishmania-type parasites.

Abstract: A compensating suspension element configuration, in Y format, which tends to minimize undesirable movements at the top of suspended pipes in floating structures and to facilitate the arrangement of incoming pipes and the correct operation to install and connect these. More particularly, this design is applicable for use in deep and ultra-deep water operation and prioritizes the operational performance of flexible pipes (risers) and other pipes that arrive at the floating structure.

Abstract: Alkali metal chlorite, particularly sodium chlorite, is produced with a level of purity superior to that expected based on the composition of the chlorine dioxide generator off-gas that is used as a raw chemical feed for chlorite manufacture. The off-gas is preferably drawn before it enters the chlorine dioxide absorption tower and is passed through a conditioning stage to then react in a liquid medium to produce an alkali metal chlorite solution from which the unreacted and produced gases are immediately separated.

Abstract: The invention relates to the use of phospholipases, v.gr. sPLA2, as an active agent in the production of pharmaceutical and/or cosmetic compositions for the treatment of diseases caused by micro-organisms, the envelope or membrane of which comprises phospholipids, particularly glycerophospholipids. In particular, said invention relates to the use of sPLA2 from Crotalus durissus terrificus venom as a biocide component for the preparation of compositions for the treatment of viral infections, particularly acquired immunodeficiency states VIH-1 and VIH-2, bacterial and parasitic infections, such as infections caused by plasmodium and leishmania-type parasites.

Abstract: Chlorine dioxide is produced at high efficiency in a continuous process effected using hydrogen peroxide as the reducing agent in a single vessel generator-evaporator-crystallizer at the boiling point of the reaction medium under sub-atmospheric pressure. The reaction medium is maintained under steady state continuous operation with a residual chlorine concentration while having no residual hydrogen peroxide concentration in the reaction medium.

Abstract: A segmented lattice rack to store fuels coming from nuclear reactors, whose walls are made of plates joined orthogonally forming a mesh defining multiple cell cavities which are longitudinally coupled forming a sandwich comprising a central part coinciding with the active part of the stored element, being from a material obtained from neutronic poisons, preferably boron treated steel; whilst the end areas coinciding with the non-active part of the stored radioactive element are of normal stainless steel, joined to each other and with the adjacent components by means of welding or pretensioning.

Abstract: A segmented lattice rack to store fuels coming from nuclear reactors, whose walls are made of plates joined orthogonally forming a mesh defining multiple cell cavities which are longitudinally coupled forming a sandwich comprising a central part coinciding with the active part of the stored element, being from a material obtained from neutronic poisons, preferably boron treated steel; whilst the end areas coinciding with the non-active part of the stored radioactive element are of normal stainless steel, joined to each other and with the adjacent components by means of welding or pretensioning.

Abstract: A rack to store fuels from nuclear reactors, formed by individual cells according to a four corner matching, in which each one of the individual cells (1) is formed by four plates (2) joined along the longitudinal edges, forming a hollow quadrangular prism and open on its bases, in which said plates have crenelated longitudinal edges, provided with protrusions (21), preferably rectangular, of variable length, of a width at least equal to the plate (2) thickness and a fillet weld backing.

Abstract: A greater yield of chlorine dioxide from a chlorine dioxide generating process is obtained by providing acidic or acidity-generating components in the product chlorine dioxide solution to provide a chlorine dioxide solution having a pH below about 5.5.

Abstract: A greater yield of chlorine dioxide from a chlorine dioxide generating process is obtained by providing acidic or acidity-generating components in the product chlorine dioxide solution to provide a chlorine dioxide solution having a pH below about 5.5.